基于CT的影像组学特征用于区分高分化与低分化结直肠腺癌
本研究回顾性纳入2008年1月至2015年8月的366例结直肠腺癌患者,在训练集(222例)中采用最小绝对收缩和选择算子方法构建影像组学特征,并在验证集(144例)中验证其术前区分高分化与低分化结直肠腺癌的效能;训练集AUC为0.812,验证集AUC为0.735,分层分析显示结肠腺癌AUC为0.725、直肠腺癌AUC为0.895。
要点
- 影像组学特征在训练集区分高分化与低分化结直肠腺癌的AUC为0.812(95%CI 0.749-0.874)。
- 验证集AUC为0.735(95%CI 0.644-0.826)。
- 分层分析中结肠腺癌AUC为0.725(95%CI 0.653-0.797),直肠腺癌AUC为0.895(95%CI 0.838-0.952)。
核心结论
- 基于CT的影像组学特征可作为术前区分高分化与低分化结直肠腺癌的补充工具,可能有助于个体化治疗。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并豁免知情同意,纳入2008年1月至2015年8月的366例结直肠腺癌患者,训练集222例、验证集144例;采用最小绝对收缩和选择算子方法在训练集中构建影像组学特征,并用独立验证集确认预测性能。
诊断标准与关键数值
- 影像组学特征区分高分化与低分化结直肠腺癌的AUC在训练集为0.812(95%CI 0.749-0.874),在验证集为0.735(95%CI 0.644-0.826)。
- 分层分析中,影像组学特征区分结肠腺癌组织学分级的AUC为0.725(95%CI 0.653-0.797),区分直肠腺癌组织学分级的AUC为0.895(95%CI 0.838-0.952)。
临床应用与阅片要点
- 作者认为该影像组学特征可作为术前区分高分化与低分化结直肠腺癌的补充工具,可能有助于个体化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and validate a computed tomography-based radiomics signature for preoperatively discriminating high-grade from low-grade colorectal adenocarcinoma (CRAC).
MATERIALS AND METHODS: This retrospective study was approved by our institutional review board, and the informed consent requirement was waived. This study enrolled 366 patients with CRAC (training dataset: n = 222, validation dataset: n = 144) from January 2008 to August 2015. A radiomics signature was developed with the least absolute shrinkage and selection operator method in training dataset. Mann-Whitney U test was applied to explore the correlation between radiomics signature and histologic grade. The discriminative power of radiomics signature was investigated with the receiver operating characteristics curve. An independent validation dataset was used to confirm the predictive performance. We further performed a stratified analysis to validate the predictive performance of radiomics signature in colon adenocarcinoma and rectal adenocarcinoma.
RESULTS: The radiomics signature demonstrated discriminative performance for high-grade and low-grade CRAC, with an area under the curve of 0.812 (95% confidence interval [CI]: 0.749-0.874) in training dataset and 0.735 (95%CI: 0.644-0.826) in validation dataset. Stratified analysis demonstrated that radiomics signature also showed distinguishing ability for histologic grade in both colon adenocarcinoma and rectal adenocarcinoma, with area under the curve of 0.725 (95%CI: 0.653-0.797) and 0.895 (95%CI: 0.838-0.952), respectively.
CONCLUSIONS: We developed and validated a radiomics signature as a complementary tool to differentiate high-grade from low-grade CRAC preoperatively, which may make contribution to personalized treatment.
引用
- Huang X, Cheng Z, Huang Y, et al. CT-based Radiomics Signature to Discriminate High-grade From Low-grade Colorectal Adenocarcinoma. Acad Radiol. 2018. PMID: 29503175. doi:10.1016/j.acra.2018.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。